Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A New IV Catheter Device Featuring Automatic and Integrated Blood Sampling

31.08.2012
<strong>Technology</strong><br>

We offer a new IV catheter for the use during emergency and disasters to automatically preserve a pre-infusion blood sample from every patient.<br><br> The new catheter system is based on existing IV devices. Its new features include an integrated blood sampling reservoir that is fixed to the IV catheter

via a flexible plastic band and remains attached to the patient following selffilling with a small blood volume until admission in the hospital. In addition, identifiers are provided comprising a housing identifier at the IV catheter and a reservoir identifier. Both identifiers have codes assigned to one another. The identifier system may comprise an electronic memory medium, in particular an RFID chip or barcode that can be read out. Upon arrival, the reservoir is disconnected from the patient and immediately sent to the laboratory for blood group typing. A prototype has been produced by injection molding process.<br><br> It has been demonstrated in a prospective phase II study that the device ensures rapid and precise blood typing in 100% of emergency patients showing that the new catheter design offered a significant advantage over the standard catheter. Furthermore, the new device increases patient safety by securing this precious very first blood sample in every case in addition to the sample taken from a central line inserted inside the hospital. Thereby two independently drawn specimens are available for ABO-typing even in circumstances with extreme time constraints.<br><br> <strong>Benefits</strong><br> <ul type="disc"> <li>Increased patient safety</li> <li>Rapid and precise ABO typing</li> <li>Redundant patient to blood product identification for increased general transfusion safety</li> <li>No interference with routine procedures</li> <li>Prevention of excessive use of 0 negative blood resources, thus allowing further cost reduction</li> </ul> <p><strong>IP Rights</strong><br> DE102004055989B4 and DE102009018837B4 granted<br> EP and US patent pending <br> (Priority Nov 2004) <br><br> <strong>Patent Owner</strong><br> Charité - Universitätsmedizin Berlin

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2828&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.

nachricht Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>